Alerts will be sent to your verified email
Verify Email
OCCL
|
AG Ventures
|
Resonance Specialtie
|
Par Drugs & Chem.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Chemicals
|
|||
|
Manufacuring Capacity - Sulphuric Acid
|
88000.0 MTPA | n/a | n/a |
|
Metals Mining & Minerals
|
|||
|
Manufacturing Capacity - Sulphur
|
39500.0 MTPA | n/a | n/a |
|
Capacity Utilization - Sulphur
|
90.0 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
8.45 % | 14.83 % | 16.79 % |
|
5yr average Equity Multiplier
|
1.44 | 1.22 | 1.28 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 1.06 | 0.92 |
|
5yr Avg Net Profit Margin
|
22.03 % | 10.72 % | 14.32 % |
|
Price to Book
|
0.41 | 1.68 | 1.13 |
|
P/E
|
10.39 | 14.91 | 12.41 |
|
5yr Avg Cash Conversion Cycle
|
26.6 Days | 111.92 Days | -12.24 Days |
|
Inventory Days
|
72.77 Days | 98.79 Days | 16.4 Days |
|
Days Receivable
|
22.55 Days | 83.71 Days | 48.97 Days |
|
Days Payable
|
80.97 Days | 91.05 Days | 90.62 Days |
|
5yr Average Interest Coverage Ratio
|
39.08 | 78.86 | 113.93 |
|
5yr Avg ROCE
|
8.49 % | 19.79 % | 20.52 % |
|
5yr Avg Operating Profit Margin
|
21.6 % | 15.26 % | 22.04 % |
|
5 yr average Debt to Equity
|
0.19 | 0.04 | 0.03 |
|
5yr CAGR Net Profit
|
-33.25 % | -8.99 % | 2.85 % |
|
5yr Average Return on Assets
|
5.78 % | 12.27 % | 13.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.76 % | 54.25 % | 73.37 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.84 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-8.4 % | 0.0 | 0.0 |
|
AG Ventures
|
Resonance Specialtie
|
Par Drugs & Chem.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|